On that subject, Mr. Livingston, could you or Mr. Keon tell us about the impact? For instance, Mr. Keon talks about Lipitor with respect to British Columbia, which has already anticipated what the cost savings are going to be if these changes in regulations are in fact reversed.
Can anybody give us a description of what impact it's going to have on their provincial health care budget?